These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 12894876)
41. Synergistic effects of verapamil on pingyangmycin-induced cytotoxicity and apoptosis in KB cells. Ho YC; Tai KW; Chang YC Oral Dis; 2007 Jan; 13(1):40-4. PubMed ID: 17241428 [TBL] [Abstract][Full Text] [Related]
42. Specific cytotoxicity of a human immunoglobulin-directed Fab'-ricin A chain conjugate. Raso V; Griffin T J Immunol; 1980 Dec; 125(6):2610-6. PubMed ID: 7430640 [TBL] [Abstract][Full Text] [Related]
43. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. Colcher D; Bird R; Roselli M; Hardman KD; Johnson S; Pope S; Dodd SW; Pantoliano MW; Milenic DE; Schlom J J Natl Cancer Inst; 1990 Jul; 82(14):1191-7. PubMed ID: 2362290 [TBL] [Abstract][Full Text] [Related]
45. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen. Temponi M; Gold AM; Ferrone S Cancer Res; 1992 May; 52(9):2497-503. PubMed ID: 1373670 [TBL] [Abstract][Full Text] [Related]
46. Applicability of monoclonal antibody Fab fragments as a carrier of neocarzinostatin in targeting chemotherapy. Otsuji E; Yamaguchi T; Tsuruta H; Yata Y; Nishi H; Okamoto K; Taniguchi K; Kato M; Kotani T; Kitamura K; Takahashi T J Surg Oncol; 1996 Feb; 61(2):149-54. PubMed ID: 8606548 [TBL] [Abstract][Full Text] [Related]
47. Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy. Ghetie MA; May RD; Till M; Uhr JW; Ghetie V; Knowles PP; Relf M; Brown A; Wallace PM; Janossy G Cancer Res; 1988 May; 48(9):2610-7. PubMed ID: 2451562 [TBL] [Abstract][Full Text] [Related]
49. Sterically stabilized anti-HER2 immunoliposomes: design and targeting to human breast cancer cells in vitro. Kirpotin D; Park JW; Hong K; Zalipsky S; Li WL; Carter P; Benz CC; Papahadjopoulos D Biochemistry; 1997 Jan; 36(1):66-75. PubMed ID: 8993319 [TBL] [Abstract][Full Text] [Related]
50. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen). Blumenthal RD; Hansen HJ; Goldenberg DM Cancer Res; 2005 Oct; 65(19):8809-17. PubMed ID: 16204051 [TBL] [Abstract][Full Text] [Related]
51. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods. Sinkule JA; Rosen ST; Radosevich JA Tumour Biol; 1991; 12(4):198-206. PubMed ID: 1651554 [TBL] [Abstract][Full Text] [Related]
52. Comparison of anti-EGFR-Fab' conjugated immunoliposomes modified with two different conjugation linkers for siRNa delivery in SMMC-7721 cells. Deng L; Zhang Y; Ma L; Jing X; Ke X; Lian J; Zhao Q; Yan B; Zhang J; Yao J; Chen J Int J Nanomedicine; 2013; 8():3271-83. PubMed ID: 24023515 [TBL] [Abstract][Full Text] [Related]
53. Antibody fragments in tumor pretargeting. Evaluation of biotinylated Fab' colocalization with recombinant streptavidin and avidin. Wilbur DS; Hamlin DK; Vessella RL; Stray JE; Buhler KR; Stayton PS; Klumb LA; Pathare PM; Weerawarna SA Bioconjug Chem; 1996; 7(6):689-702. PubMed ID: 8950488 [TBL] [Abstract][Full Text] [Related]
54. [One amino acid mutation in an anti-CD20 antibody fragment that affects the yield bacterial secretion and the affinity]. Liu YX; Xiong DS; Fan DM; Shao XF; Xu YF; Zhu ZP; Yang CZ Sheng Wu Gong Cheng Xue Bao; 2003 May; 19(3):272-6. PubMed ID: 15969005 [TBL] [Abstract][Full Text] [Related]
55. [Effect of pingyangmycin on the growth and cell cycle of human vascular endothelial cells]. Kong WD; Li YH; Zeng QL; Chen Y; He XF Di Yi Jun Yi Da Xue Xue Bao; 2003 Aug; 23(8):830-2, 836. PubMed ID: 12919911 [TBL] [Abstract][Full Text] [Related]
56. Doxorubicin-conjugated anti-midkine monoclonal antibody as a potential anti-tumor drug. Inoh K; Muramatsu H; Torii S; Ikematsu S; Oda M; Kumai H; Sakuma S; Inui T; Kimura T; Muramatsu T Jpn J Clin Oncol; 2006 Apr; 36(4):207-11. PubMed ID: 16611663 [TBL] [Abstract][Full Text] [Related]
57. The spatial distribution of immunotoxins in solid tumors: assessment by quantitative autoradiography. Sung C; Dedrick RL; Hall WA; Johnson PA; Youle RJ Cancer Res; 1993 May; 53(9):2092-9. PubMed ID: 8481911 [TBL] [Abstract][Full Text] [Related]
58. Evaluation of the 323/A3 monoclonal antibody and the use of technetium-99m-labeled 323/A3 Fab' for the detection of pan adenocarcinoma. Pak KY; Nedelman MA; Fogler WE; Tam SH; Wilson E; Van Haarlem LJ; Colognola R; Warnaar SO; Daddona PE Int J Rad Appl Instrum B; 1991; 18(5):483-97. PubMed ID: 1917518 [TBL] [Abstract][Full Text] [Related]
59. [Inhibitory effect of pingyangmycin on human liver cancer and stomach cancer xenografts in nude mice]. Jiang M Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):357-9. PubMed ID: 2470565 [TBL] [Abstract][Full Text] [Related]